GridAI Technologies (GRDX) Current Leases (2020 - 2026)
GridAI Technologies' (GRDX) quarterly Current Leases came in at $135609.0 in Q2 2026, little changed on a YoY basis from $135609.0 in Q2 2025, and little changed quarter-over-quarter from $135609.0 in Q4 2025.
Analysis
GridAI Technologies (GRDX) Current Leases (2020 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Current Leases for 7 consecutive years, with $135609.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Leases changed 0.0% year-over-year to $135609.0; the trailing twelve-month figure through Jun 2026 stood at $135609.0 (changed 0.0% YoY), and the FY2025 full-year result was $135609.0, up 66.37% from the prior year.
- Current Leases held at $135609.0 in Q2 2026 per GRDX's latest filing, from $135609.0 in the prior quarter.
- Across five years, Current Leases topped out at $135609.0 in Q1 2025 and bottomed at $62673.0 in Q2 2022.
- Historically, Current Leases has averaged $90300.7 across 5 years, with a median of $74324.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Current Leases sank 32.07% in 2022, then jumped 90.42% in 2025.
- Over 5 years, Current Leases stood at $66151.0 in 2022, then advanced by 1.45% to $67111.0 in 2023, then grew by 21.46% to $81510.0 in 2024, then soared by 66.37% to $135609.0 in 2025, then changed by 0.0% to $135609.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $135609.0, $135609.0, and $135609.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.74 Bn | 192.75 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.96 Bn | 176.78 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.20 Bn | 123.35 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.05 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.08 Bn | 29.78 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 31.91 Bn | 30.62 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.22 Bn | 29.22 Bn | 1.16 Mn | 12.38 Mn |
| 10 | GridAI Technologies | 18.97 Mn | 18.97 Mn | -36,514.00 | 135,609.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 135,609.00 |
| Dec 31, 2025 | 135,609.00 |
| Sep 30, 2025 | 135,609.00 |
| Jun 30, 2025 | 135,609.00 |
| Mar 31, 2025 | 135,609.00 |
| Dec 31, 2024 | 81,510.00 |
| Sep 30, 2024 | 79,454.00 |
| Jun 30, 2024 | 77,432.00 |
| Mar 31, 2024 | 71,216.00 |
| Dec 31, 2023 | 67,111.00 |
| Sep 30, 2023 | 65,322.00 |
| Jun 30, 2023 | 63,564.00 |
| Mar 31, 2023 | 67,936.00 |
| Dec 31, 2022 | 66,151.00 |
| Sep 30, 2022 | 64,397.00 |
| Jun 30, 2022 | 62,673.00 |
| Dec 31, 2021 | 77,989.00 |
| Sep 30, 2021 | 94,794.00 |
| Mar 31, 2021 | 56,702.00 |
| Dec 31, 2020 | 57,417.00 |